Why is diphenhydramine (Benadryl) not recommended for children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Why Diphenhydramine (Benadryl) Is Not Recommended for Children

Diphenhydramine should not be used in children under 6 years of age because it has no proven efficacy for cough or cold symptoms and carries significant risks of toxicity, including death. 1, 2

FDA and Guideline Restrictions

  • The FDA drug label explicitly states "Do not use" for children under 6 years of age 2
  • The American Academy of Pediatrics and FDA recommend against OTC cold medications in children under 4 years due to potential toxicity and lack of proven efficacy 1
  • FDA advisory committees recommended in 2007 that OTC cough and cold medications should not be used in children below 6 years 1, 3
  • Between 1969-2006, there were 69 fatalities associated with antihistamines (including diphenhydramine) in children under 6 years 1

Lack of Efficacy

  • Diphenhydramine was no different than placebo in reducing nocturnal cough or sleep disturbance in both children and parents in randomized controlled trials 4
  • Systematic reviews show antihistamines are no more likely than placebo to reduce acute cough in children 4
  • In contrast to adults, the efficacy of antihistamines in relieving cough in children is minimal, if any 4
  • Neither antihistamine monotherapy nor combinations with decongestants were effective in children ≤15 years of age 4

Safety Concerns and Toxicity Profile

  • Accidental unsupervised ingestions account for 74.7% of diphenhydramine-only cases in children, with the majority (79.5%) occurring in children 2 to <4 years of age 5
  • Common adverse events include tachycardia (53.4%), hallucinations (46.5%), somnolence (34.7%), agitation (33.9%), and mydriasis (26.3%) 5
  • Diphenhydramine appears to be associated with a high frequency of severe adverse effects and toxicity compared to other cough and cold medications 6
  • Medication errors from incorrect dosing are common, particularly in young children, and can lead to unintentional overdose 1

Specific Dosing Thresholds for Toxicity

  • Children less than 6 years of age who ingest at least 7.5 mg/kg of diphenhydramine should be referred to an emergency department 7
  • Patients 6 years and older who ingest at least 7.5 mg/kg or 300 mg (whichever is less) should be referred to an emergency department 7
  • The narrow therapeutic window in young children makes even therapeutic errors potentially dangerous 1

Critical Pitfalls to Avoid

  • Never use diphenhydramine "to make a child sleepy" - this is explicitly contraindicated on the FDA label 2
  • Do not assume that because a product is available OTC, it is safe for young children 1
  • Avoid using multiple products containing diphenhydramine, as this is a common cause of adverse events 1
  • Liquid pediatric formulations (51.7% of cases) and solid pediatric formulations (24.0%) are most commonly involved in adverse events, so child-resistant packaging alone is insufficient protection 5

Safer Alternatives for Children

  • For children over 1 year of age with acute cough, honey offers more relief than diphenhydramine or placebo 1, 8
  • Vapor rub, zinc sulfate, and buckwheat honey improve symptoms in children 8
  • Hypertonic saline solution can increase cough clearance without drug interactions 3

Limited Exception: Anaphylaxis Only

  • Diphenhydramine at 1-2 mg/kg (25-50 mg/dose) parenterally is appropriate only as second-line therapy to epinephrine in anaphylaxis, never as monotherapy 4
  • In anaphylaxis management, diphenhydramine combined with ranitidine is superior to diphenhydramine alone, but both are second-line to epinephrine 4

References

Guideline

Safe Age for Over-the-Counter Cold Medications in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Safety of OTC Cough Medicine with Vyvanse

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Adverse events associated with diphenhydramine in children, 2008-2015.

Clinical toxicology (Philadelphia, Pa.), 2020

Research

Restricting cough and cold medicines in children.

Journal of paediatrics and child health, 2012

Research

Treatment of the common cold in children and adults.

American family physician, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.